Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System
Patient with clinical suspicion of prostate cancer referred for a multiparametric MRI of the prostate before a first series of biopsies or before new biopsies after one or more series of negative biopsies
PSA ≤ 30 ng / ml
Clinical stage ≤ T2c
Affiliation or beneficiary of a social security scheme
You may not be if
Men over 80 years of age
PSA\> 30 ng / ml
Stage T3 or T4 on digital rectal examination
Previous prostate biopsy performed within 12 months
History of prostate cancer diagnosed by biopsy or endourethral resection.
History of pelvic radiotherapy regardless of the cause.
History of total or focal treatment for prostate cancer.
History of hormone therapy
MRI performed more than 3 months before biopsy
Prostate MRI performed on a machine other than the center's machines accredited for the study.
Presence of a hip prosthesis
Contraindication to performing an MRI
Contraindication to performing prostate biopsy
Patient subject to a legal protection measure or deprived of liberty
Subject participating or having participated in interventional medical research with an exclusion period still in progress
Misunderstanding of the French language
Clareo Health | Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System
